NEW
YORK, Sept. 30, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Orthofix
Medical Inc. (NASDAQ: OFIX).
Shareholders who purchased shares of OFIX during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=105564&from=4
CLASS PERIOD: October 11,
2022 to September 12, 2023
ALLEGATIONS: According to the filed complaint, defendants
made false and/or misleading statements and/or failed to disclose
that Orthofix's management team was engaged in "repeated
inappropriate and offensive conduct that violated multiple code of
conduct requirements," which was also "inconsistent with the
Company's values and culture." This revelation was particularly
egregious as it followed assurances that Orthofix's management team
consisted of individuals committed to conducting business in
accordance with the highest ethical and legal standards, and
further, that these individuals believed in and fostered a strong
performance-based culture focused on integrity, collaboration,
innovation, diversity, and corporate responsibility.
DEADLINE: October 21, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=105564&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of OFIX during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is October 21, 2024. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-orthofix-medical-incofix-of-a-class-action-lawsuit-and-an-upcoming-deadline-302261451.html
SOURCE The Gross Law Firm